Patent classifications
A61L15/20
Multi-Layer Wound Care Device Having Absorption and Fluid Transfer Properties
This disclosure relates to a multi-layer wound care device having absorption and fluid transfer properties. The wound care device contains capillary force one-way pumps that are capable of transporting fluid, such as wound exudate, away from a wound site to the opposite side of the wound care device, which functions as a segregated fluid reservoir. This fluid transport mechanism generally aids in reducing wound maceration by removing excess wound fluid and the protease enzymes and infectious bacteria contained within the wound fluid. The wound care device performs this function, often times for multiple days, without the loss of the physical integrity of the wound care device. In addition to providing a uni-directional fluid transport mechanism, the wound care device provides improved absorption properties.
SUPERABSORBENT MATERIAL ABSORBENT CAPACITY INCREASE WITH USE OF MULTIFUNCTIONAL CHEMICAL AGENTS
The present invention discloses a method for increasing absorbent capacity of a superabsorbent material (SAM) by treating the SAM with a selected multifunctional chemical agent (MCA) or a combination of a plurality of selected MCAs. The selected MCA(s) may interact with the polymer chain of the SAM through one or a plurality of mechanisms that enhance the absorbent capacity of the SAM. In various preferred embodiments, SAMs include polyelectrolytes that are made from polymerizing mixtures of acrylic acid monomer and acrylic acid sodium salt, and L-arginine or lysine is selected as the MCA.
SUPERABSORBENT MATERIAL ABSORBENT CAPACITY INCREASE WITH USE OF MULTIFUNCTIONAL CHEMICAL AGENTS
The present invention discloses a method for increasing absorbent capacity of a superabsorbent material (SAM) by treating the SAM with a selected multifunctional chemical agent (MCA) or a combination of a plurality of selected MCAs. The selected MCA(s) may interact with the polymer chain of the SAM through one or a plurality of mechanisms that enhance the absorbent capacity of the SAM. In various preferred embodiments, SAMs include polyelectrolytes that are made from polymerizing mixtures of acrylic acid monomer and acrylic acid sodium salt, and L-arginine or lysine is selected as the MCA.
SELF-FUELED PARTICLES FOR PROPULSION THROUGH FLOWING AQUEOUS FLUIDS
A simple, self-propelling particle system is disclosed that can deliver a cargo through flowing aqueous solutions. This disclosure provides a non-aqueous composition comprising: (i) particles formed of a carbonate salt and having an average diameter of about 100 μm or less; and (ii) an acid in solid form. The particles may be associated with a cargo molecule or particle. In mouse models of severe hemorrhage, the propelled particles are able to deliver a procoagulant enzyme and halt bleeding.
SELF-FUELED PARTICLES FOR PROPULSION THROUGH FLOWING AQUEOUS FLUIDS
A simple, self-propelling particle system is disclosed that can deliver a cargo through flowing aqueous solutions. This disclosure provides a non-aqueous composition comprising: (i) particles formed of a carbonate salt and having an average diameter of about 100 μm or less; and (ii) an acid in solid form. The particles may be associated with a cargo molecule or particle. In mouse models of severe hemorrhage, the propelled particles are able to deliver a procoagulant enzyme and halt bleeding.
Water soluble farnesol analogs and their use
Farnesol analogs, along with their related products (e.g., treatment compositions, wipes, absorbent articles, etc.) and their methods of formation, are provided. The farnesol analog includes a hydrophilic end group (e.g., a hydroxyl end group or a carboxylic acid end group) attached to farnesol via a covalent linkage (e.g., an ester group or an ether group).
Water soluble farnesol analogs and their use
Farnesol analogs, along with their related products (e.g., treatment compositions, wipes, absorbent articles, etc.) and their methods of formation, are provided. The farnesol analog includes a hydrophilic end group (e.g., a hydroxyl end group or a carboxylic acid end group) attached to farnesol via a covalent linkage (e.g., an ester group or an ether group).
Binary odor control system for absorbent articles
Cellulosic pulp structures integrating unreacted quantities of an inorganic peroxide and a destabilizing acid, as binary components of an odor control system, absorbent articles incorporating such structures, and various methods of forming the same, are disclosed herein. The components are adapted to react in the presence of an aqueous fluid to produce hydrogen peroxide, thereby providing an antimicrobial and odor mitigating effect.
Binary odor control system for absorbent articles
Cellulosic pulp structures integrating unreacted quantities of an inorganic peroxide and a destabilizing acid, as binary components of an odor control system, absorbent articles incorporating such structures, and various methods of forming the same, are disclosed herein. The components are adapted to react in the presence of an aqueous fluid to produce hydrogen peroxide, thereby providing an antimicrobial and odor mitigating effect.
Absorbent article
Absorbent article suppressing occurrence of malodor after use while preventing a rash on a wearer's skin. The absorbent article includes an absorbent body, and a fumaric acid-supported sheet disposed on a skin surface side of the absorbent body. The fumaric acid-supported sheet is a sheet which supports fumaric acid particles having an average particle diameter of 30 μm or less, and/or a sheet in which at least a part of constituent fibers is coated with fumaric acid. When being in contact with the body fluid or the like, fumaric acid is not immediately but slowly dissolved so that alkalization at the area around fumaric acid can be prevented over a long period of time. In addition, fumaric acid has an action of inhibiting proliferation of putrefactive bacteria and, therefore, can prevent occurrence of malodor from the absorbent article having absorbed the body fluid or the like.